Siga Technologies INC Accrued Bonuses, Current
Siga Technologies INC (SIGA) had Accrued Bonuses, Current of $1.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Bonuses, Current $1.93M.
- 2026-03-31: Accrued Bonuses, Current $1.27M.
- 2025-12-31: Accrued Bonuses, Current $3.13M; Accrued Bonuses, Current as first filed $3.30M.
- 2025-09-30: Accrued Bonuses, Current $2.74M.
| Period end | Accrued Bonuses, Current | Accrued Bonuses, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.93M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $3.13M 10-Q · filed 2026-08-06 | $3.30M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.74M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.47M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $637.75K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $2.10M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.78M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.37M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.37M 10-K · filed 2025-03-11 | $2.79M 10-K · filed 2024-03-12 |
| 2023-09-30 | $2.21M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.48M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $801.89K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.38M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $2.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.42M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $716.68K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.81M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $2.42M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.67M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $853.83K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.93M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $2.50M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.75M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $955.49K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.97M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $2.02M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $764.06K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $2.60M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $1.28M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $893.89K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $454.49K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $2.54M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $1.68M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.19M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $676.58K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.36M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $1.38M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $466.63K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $780.89K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $580.80K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $802.25K 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $572.50K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $405.00K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $17.50K 10-K · filed 2016-03-04 | |
| 2014-06-30 | $772.50K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $401.25K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 | |
| 2013-09-30 | $1.10M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $803.59K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $365.55K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $250.00K 10-K · filed 2014-03-10 | |
| 2012-09-30 | $1.21M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $838.64K 10-Q · filed 2012-08-06 | |
| 2011-12-31 | $1.07M 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |